Mizuho Maintains Outperform on CVS Health, Raises Price Target to $115

Benzinga Newsdesk www.benzinga.com Positive 88.3%

Neg 0% Neu 0% Pos 88.3%

Mizuho analyst Ann Hynes maintains CVS Health (NYSE:CVS) with a Outperform and raises the price target from $110 to $115.